Ancient movements take on Parkinson's: tai chi and Qi-Gong face off

NCT ID NCT07662837

Recruiting now Disease control Sponsor: Lahore University of Biological and Applied Sciences Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares Tai Chi and Qi-Gong, two gentle movement therapies, to see which better improves balance and motor function in people with stage I Parkinson's disease. Fifty participants aged 50 to 65 will receive either Tai Chi or Qi-Gong alongside standard physical therapy for 8 weeks. Researchers will measure changes in motor function and balance using standard rating scales to identify the more effective rehabilitation approach.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Tai Chi and Qi-Gong
What this could lead to: If one approach proves more effective, it could point toward a preferred rehabilitation therapy for early Parkinson's, potentially slowing motor decline and reducing fall risk.
What could go wrong: This is a small, early-phase study with only 50 participants, so results may not apply broadly. The interventions are complementary and not expected to cure Parkinson's.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE (DISORDER) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PARKINSON DISEASE (DISORDER)

Contacts and locations

Locations

Ghurki Trust and Teaching Hospital
RECRUITING

Lahore, Punjab Province, Pakistan
The Meer's Physiotherapy and Rehabilitation
RECRUITING

Lahore, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.